Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation

Yuichi Murayama1, Miyako Yoshioka, Hiroko Horii

  • 1Prion Disease Research Center, National Institute of Animal Health, Ibaraki, Japan. ymura@affrc.go.jp

Insights

Protein misfolding cyclic amplification (PMCA) offers a faster method for detecting prion infectivity after sterilization. This in vitro technique accurately assesses prion inactivation, significantly reducing detection time compared to traditional bioassays.

Area of Science:

  • Biochemistry
  • Infectious Diseases
  • Neuroscience

Background:

  • Prion diseases are linked to abnormal prion proteins (PrP(Sc)) that resist standard sterilization.
  • Bioassays are the standard for detecting prion infectivity but are time-consuming, taking hundreds of days.

Purpose of the Study:

  • To evaluate protein misfolding cyclic amplification (PMCA) as a rapid method for assessing prion inactivation.
  • To compare PMCA results with traditional bioassays for prion infectivity detection.

Main Methods:

  • Scrapie-infected hamster brains were subjected to dry heating and autoclaving under various conditions.
  • Residual prion infectivity was assessed using a bioassay.
  • Prion protein (PrP(Sc)) amplification and detection were performed using protein misfolding cyclic amplification (PMCA).

Main Results:

  • PMCA results showed good agreement with bioassay findings for prion inactivation.
  • Protease-resistant PrP (PrP(res)) signals were detected by PMCA in samples autoclaved below 150°C, where bioassays indicated infectivity.
  • PMCA detected residual infectivity within 6 days (three rounds), drastically faster than the bioassay.

Conclusions:

  • PMCA is a rapid and reliable method for assessing prion inactivation by heat sterilization.
  • PMCA significantly accelerates the detection of residual prion infectivity compared to conventional bioassays.